Singapore markets closed

Supernus Pharmaceuticals Inc (S49.SG)

Stuttgart - Stuttgart Delayed price. Currency in EUR
Add to watchlist
25.000.00 (0.00%)
As of 08:09AM CEST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-15,508
1,316
60,711
53,424
126,950
-
Depreciation & amortisation
85,007
84,859
85,543
32,595
18,141
-
Deferred income taxes
-30,761
-25,714
-26,324
-4,994
568
-
Stock-based compensation
26,350
26,759
17,568
17,910
16,561
-
Change in working capital
-690
-9,137
-24,243
3,570
-36,515
-
Accounts receivable
-6,785
18,765
-16,366
3,867
-34,607
-
Inventory
9,951
6,110
-17,858
-14,580
-10,124
-
Accounts payable
-15,720
-36,287
-19,163
18,179
8,272
-
Other working capital
99,839
110,534
116,414
125,082
134,709
-
Other non-cash items
12,945
12,935
352
24,551
19,935
-
Net cash provided by operating activities
100,360
111,085
116,826
127,127
138,399
-
Cash flows from investing activities
Investments in property, plant and equipment
-521
-551
-412
-2,045
-3,690
-
Acquisitions, net
-
0
0
-311,692
-298,541
-
Purchases of investments
-295,321
-101,621
-406,990
-311,573
-95,890
-
Sales/maturities of investments
273,167
370,901
190,739
530,509
378,422
-
Other investing activities
-
-
-
-
-241
1,349
Net cash used for investing activities
-22,675
268,729
-216,663
-81,913
-34,699
-
Cash flows from financing activities
Debt repayment
-480,863
-495,500
0
-138,315
-802
-
Common stock issued
7,264
6,610
12,423
7,095
4,361
-
Other financing activities
-2,885
-1,990
-22,900
-
-
-
Net cash used provided by (used for) financing activities
-476,484
-397,880
-10,477
-130,420
3,559
-
Net change in cash
-398,799
-18,066
-110,314
-85,206
107,259
-
Cash at beginning of period
462,200
93,120
203,434
288,640
181,381
-
Cash at end of period
63,401
75,054
93,120
203,434
288,640
-
Free cash flow
Operating cash flow
100,360
111,085
116,826
127,127
138,399
-
Capital expenditure
-521
-551
-412
-2,045
-3,690
-
Free cash flow
99,839
110,534
116,414
125,082
134,709
-